Le Lézard
Classified in: Science and technology, Business
Subject: AWD

Vanilla Awarded Technology Disruptor in WealthManagement.com Industry Awards 2020


NEW YORK, Sept. 21, 2020 /PRNewswire-PRWeb/ -- On September 10, 2020, Vanilla was presented with an award from the 6th WealthManagement.com Industry Awards under the category "Disruptors: Technology."

The WealthMangement.com Industry Awards recognizes companies that make an exceptional impact in the world of financial advisors. Companies who make a true difference in the day-to-day success of financial advisors. This year, more than 200 companies were nominated across 73 different categories. Companies ranging Carson Group, Fidelity Investments, Morning Star Inc, and more, competing in categories like Asset Managers, Disruptors, Family Offices, Individual RIA Firm Leaders, Technology Providers, and more. See the full list of finalists and categories here, https://wealthiescircle.com/.

Vanilla was announced the winner in the category "Disruptors: Technology" for creating a new standard in estate planning technology. Vanilla's platform helps advisors provide new value to their clients by proactively managing their estate planning, from visualizations of their current estate to ongoing administration. With a suite of tools ranging from core document preparation, data-driven estate plan diagrams, and robust visualizations of complex estates, Vanilla helps advisors serve their clients in a new way.

About Vanilla:
Vanilla was founded in 2019 by AdvicePeriod's Steve Lockshin to help advisors deliver more estate planning value to their clients. Initially built for internal use, it quickly became clear that the application and need were much broader than originally contemplated.

Since then, Vanilla has built out a suite of products with the goal of reinventing the estate planning experience, end-to-end. From document preparation, robust visualizations of complex estates, detailed diagrams of how assets transfer to future generations, to ongoing estate administration, Vanilla is continuing to build out tools that allow advisors to do more for their clients.

Vanilla has partnered with some of the industry's most influential RIA's, law firms, and financial technology platforms to help distribute their technology, allowing them to deliver far more estate planning value to their clients. Visit https://www.justvanilla.com/ to learn more.

About WealthManagement.com
WealthManagement.com, an Informa business, provides everything wealth professionals need to know to stay knowledgeable about the industry, build stronger relationships, improve their practice, and grow their business?all from one site.

 

SOURCE Vanilla


These press releases may also interest you

at 10:10
HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today that two HighField abstracts have been accepted with one poster presentation at the American Society of Clinical...

at 10:10
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of two abstracts for poster presentation...

at 10:07
W.W. Grainger, Inc. announced today that its board of directors approved a quarterly cash dividend of $2.05 per share, an increase of 10% from the most recent company dividend. The dividend is payable on June 1, 2024, to shareholders of record on...

at 10:05
Udemy , a leading online skills marketplace and learning platform, today released its Q1 2024 Global Workplace Learning Index, a quarterly report highlighting in-demand skills that help companies remain competitive in a fast-changing global economy....

at 10:05
RouteSmart Technologies will be unveiling RouteSmart for ArcGIS Pro, a revolutionary solution designed to transform snowplow operations, at the APWA North American Snow Show. This advanced solution leverages sophisticated algorithms to address the...

at 10:05
Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced two presentations, including an oral presentation on the Phase 1 first-in-human study of OBX-115, a novel engineered...



News published on and distributed by: